Skip to content

Advertisement

  • Case Report
  • Open Access

Primary angiosarcoma arising in an angiomyolipoma of the kidney: case report and literature review

  • 1,
  • 1,
  • 1,
  • 1,
  • 1,
  • 1 and
  • 1Email author
Diagnostic Pathology201813:53

https://doi.org/10.1186/s13000-018-0730-z

  • Received: 24 April 2018
  • Accepted: 30 July 2018
  • Published:

Abstract

Background

Primary angiosarcoma of the kidney is a rare and aggressive malignant tumor presenting with a recognizable vascular differentiation. Its prognosis is fatal and the pathogenesis remains unclear. Renal angiomyolipoma is a relatively infrequent renal cortical neoplasm and is composed of variable proportions of adipose tissue, spindle cells, epithelioid smooth muscle cells and abnormal thick-walled blood vessels.

Case presentation

Here, we reported a case in which a 64-year-old woman presenting with the chief complaint of a progressively enlarged mass in the left abdomen. Abdominal computed tomography confirmed presence of a tumor measuring 18 cm × 11 cm in the left posterior renal fascia. Microscopic examination and immunohistochemical staining confirmed co-existence of angiomyolipoma and angiosarcoma. Furthermore, the two components interspersed with each other and there were transitional zones between them.

Conclusions

In this case, we described for the first time a primary renal angiosarcoma possibly arising in a pre-existing angiomyolipoma of the kidney.

Keywords

  • Primary angiosarcoma
  • Angiomyolipoma
  • Kidney
  • Pathology

Background

Angiosarcoma (AS) is a rare and aggressive malignant tumor presenting with a recognizable vascular differentiation. It occurs mainly in the adulthood and elderly, with occasional cases reported in children [1]. Angiosarcoma is usually located in the skin, superficial soft tissue or other organs, such as bone, breast or liver [2]. Primary renal angiosarcoma is extremely rare and its prognosis is poor due to the rapid local recurrence and bloodstream dissemination [3].

Renal angiomyolipoma (AML) is the most common mesenchymal tumor of the kidney and it was first reported by Morgan in 1951 [4]. The World Health Organization (WHO) defines renal angiomyolipoma as a benign mesenchymal tumor composed of variable proportions of adipose tissue, spindle cells, epithelioid smooth muscle cells and abnormal thick-walled blood vessels [5]. It belongs to a family of lesions called perivascular epithelioid cell tumors (PEComas), which are characterized by proliferation of perivascular epithelioid cells [5]. They are not always located in the kidney and also can be found in uterus, liver, fallopian tubes and spleen [6].

Here we described a case of primary renal angiosarcoma concomitant with an AML in a 64-year-old woman. To our best knowledge, this is the first report of a renal angiosarcoma arising in an AML background.

Case presentation

A 64-year-old woman presented to our hospital with the chief complaint of a progressively enlarged mass in the left abdomen accompanied with flank pain, fatigue and weight loss for the last few months. Physical examination revealed a well-defined mass on the left abdomen. Routine blood tests showed that hemoglobin was 111 g/L (normal range was 115 g/L to 150 g/L) and hematocrit was 34% (ranging 35 to 45%), indicating anemia. The remaining blood tests were normal. Abdominal computed tomography (CT) confirmed presence of a tumor measuring 18 cm × 11 cm on the left posterior perinephric capsule (Fig. 1a), with enhanced density after administration of contrast medium (Fig. 1b-d).
Fig. 1
Fig. 1

The complex lesion of the kidney on computed tomography (CT). a. Plain CT image showed a large mixed density mass in the left renal fascia, which was closely related to the left kidney (yellow arrows). b. Dynamic contrast CT (arterial phase) showed the mass was obviously uneven, and small vessels could be seen around the lesion (yellow arrows). c. Dynamic contrast CT (venous phase) showed the enhancement degree of the mass decreased compared to that in the arterial phase (yellow arrows). d. Dynamic contrast CT (equilibrium phase) showed the degree of enhancement was similar to that of venous phase (yellow arrows)

The mass was excised and a pathologic consultation was requested. On macroscopic examination, the specimen was composed of a giant nodular mass measuring 18 cm × 11 cm × 9 cm with a little attached portion of normal renal cortex. The outer surface of the mass was smooth and brownish in color. Sectioning revealed patchy areas of hemorrhage and necrosis. Microscopic examination was performed on paraffin-embedded sections stained with hematoxylin and eosin. Histopathological examination revealed that two components interspersed with each other within this tumor and there were transitional zones between the two (Fig. 2a). One component comprised of atypical cells arranged in multiple architectures. Some well-differentiated fields were composed of irregular interanastomosing vascular spaces or channels lined with discrete and large endothelial cells with variable degrees of cytological pleomorphism, nuclear atypia and multilayering (Fig. 2b). Many of these structures contained red blood cells, indicating a vascular lesion. Some poorly-differentiated fields were composed predominantly of atypical epithelioid cells arranged in solid areas (Fig. 2c). The epithelioid cells had irregular round or oval nuclei with prominent nucleoli, abundant cytoplasm and a high degree of nuclear atypia. Tumorous necrosis was obvious (Fig. 2d), and up to five mitotic figures per high-power field were observed (Fig. 2e). The other component (including the areas adjacent to the renal cortex) was primarily composed of adipose tissue, smooth muscle cells and abnormal thick-walled blood vessels (Fig. 2f and g), indicating the feature of AML. But in multifocal areas of AML, atypical cells with the morphological and structural characteristics resembling those of the first component were observed (Fig. 2h and i).
Fig. 2
Fig. 2

Angiosarcoma (AS) and angiomyolipoma (AML) in the renal cortex. a. The transitional zones between AS and AML (× 200); b. The well-differentiated areas of AS (× 200); c. The poorly-differentiated areas of AS (× 200); d. Tumorous necrosis in the lesion (× 200); e. Mitotic figures per high-power field (× 400); f (× 100) and g (× 200). AML regions in the lesion; h and i. Atypical cells with the morphological and structural characteristics resembling AS in areas of AML (× 200)

An immunohistochemical study was performed on formalin-fixed paraffin-embedded tissue block to define the histogenesis of the lesion. Several pre-diluted antibodies against ERG, CD31, CD34, Ki-67, S-100, HMB45, Melan A, SMA, Actin, Vimentin, CD10, EMA, PAX-8, RCC and pan-cytokeratin were used. The results showed that the atypical cells in the areas of the first component were reactive strongly and diffusely to ERG (Fig. 3a), CD31 (Fig. 3b), CD34 (Fig. 3c), and Vimentin, but negative to HMB45 (Fig. 3e), Melan-A (Fig. 3f), SMA, Actin and S-100. In addition, the cells were also negative to pan-cytokeratin, PAX-8, RCC, EMA and CD10. The cell proliferation marker Ki-67 (MIB-1) was positive in about 50% of the atypical cells (Fig. 3d). To sum up, the immunohistochemical results supported the diagnosis of angiosarcoma. On the contrary, the cells in the areas of AML were reactive strongly and diffusely to Melan-A (Fig. 3g) and SMA (Fig. 3h), focally to HMB45 (Fig. 3i) and Actin, confirming the diagnosis of AML. However, the atypical cells in the AML background were positive to ERG (Fig. 4a), CD31 (Fig. 4b), CD34 (Fig. 4c), but negative to HMB45 (Fig. 4d), Melan-A (Fig. 4e) and SMA (Fig. 4f). On the basis of clinical, histologic and immunohistochemical findings, a final diagnosis of renal angiosarcoma concomitant with an AML was made.
Fig. 3
Fig. 3

Different expressions of ERG (a), CD31 (b), CD34 (c), Ki-67 (d), HMB45 (e), Melan-A (f) in AS (paired with H&E in Fig. 2b) and Melan-A (g), SMA (h) and HMB45 (i) in AML (paired with H&E in Fig. 2g) (× 200)

Fig. 4
Fig. 4

Different expressions of ERG (a), CD31 (b), CD34 (c), HMB45 (d), Melan-A (e) and SMA (f) in the atypical cells with the morphological and structural characteristics resembling AS in areas of AML (paired with H&E in Fig. 2i) (× 200)

Three months after the surgery, the patient presented again with progressive abdominal distention for about one week. CT examination showed diffuse thickening and nodular deposits of omentum in the left lower abdomen and a lot of abdominal and pelvic effusion. Combined with the history and imaging examinations, extensive abdominal metastasis was highly suspicious. The patient received intraperitoneal cisplatin perfusion and symptomatic treatments such as paracentesis and analgesia. However, one month later, she died.

Discussion

Primary renal angiosarcoma is a rare malignant vascular tumor originating from endothelial cells. It has an extremely high mortality rate due to rapid growth and distant metastasis at the time of diagnosis or shortly afterwards. Angiosarcoma is considered to originate from endothelial cells in tissues or from circulating stem cells which are recruited from bone marrow or locations of extra-medullary hematopoiesis [7, 8]. Gene amplifications or genetic mutations for p53, VEGF, Ras, Myc and MDM2 have been explored in a great deal of angiosarcoma tissues, but the genetic changes found are complicated [9]. Although the exact etiology is unknown, many different environmental factors are associated with the occurrence of angiosarcoma. These factors include exposure to arsenic, vinyl chloride, thorium dioxide, radiotherapy and chronic lymphedema of any causes [2, 1014].The diagnosis of this lesion is extremely difficult if not impossible if only the clinical and radiological features are considered. Therefore, the importance of post-operative pathological examination cannot be ignored. Studies showed that angiosarcoma could occur on the background of other tumors, such as schwannoma [15, 16], hemangioma and lymphangioma [17, 18], malignant germ cell tumor [19], leiomyoma [20] and tuberous sclerosis complex (TSC)-associated lymphangioleiomyomatosis (LAM) [21], all of which were very rare.

Renal AMLs are uncommon neoplasms accounting for less than 1% of surgically removed tumors [22]. And they are often associated with tuberous sclerosis complex (TSC), which is an autosomal dominant genetic disease because of losses of TSC1 (9q34) or TSC2 (16p13.3) genes [23, 24]. In recent years, great advances have been made in understanding TSC and related lesions. In particular, TSC genes seem to play an important role in regulating mTOR pathway [25]. However, most AMLs occur sporadically [22]. Similar changes of the TSC genes have been found in both TSC-related AMLs and sporadic cases. Kenerson et al. [26] have recently demonstrated that mTOR activity is increased in sporadic, non-TSC-related AMLs. In patients with TSC, AMLs are found predominantly in 30 to 40 years old women and they tend to be asymptomatic, small, multifocal, and bilateral. On the other hand, sporadic AMLs are seen in 40 to 70 years old women and are usually larger, symptomatic, single, and unilateral [27].

We described here, for the first time, a patient who had renal angiosarcoma concomitant with an AML verified by immunohistochemical staining. In this case, there was no definite boundary between the two components. On the contrary, they were interspersed with each other and there were transitional zones between them. In this context, the possibility of a collision tumor could be ruled out. Furthermore, in several areas of AML, we could find multifocal atypical cells with the morphological and structural characteristics resembling those of angiosarcoma. Immunohistochemical staining verified their vascular origin. Taking into account the above mentioned findings, we inferred that in this case, angiosarcoma might occur in a pre-existent AML. However, the etiology and pathogenesis are still very speculative. Explanations might be as follows. Firstly, angiosarcoma cells might originate from vascular endothelial cells in AML lesions. Previous studies have suggested a crucial role of the mTOR pathway in the malignant transformation of endothelial cells. Besides, Italiano et al. [28, 29] reported in their studies that mTOR pathway was activated in a subset of angiosarcomas. Considering the role of mTOR pathway in the pathogenesis of AML, we are more inclined to this possibility. However, we have no direct evidence. Secondly, angiosarcoma cells might have originated from lymphatic endothelial cells in AML lesions. Like Stewart-Treves syndrome, long-term postmastectomy lymphedema and regional immune deficiency are considered to be an important factor in the complication of angiosarcoma. Hayashi et al. [21] speculated in their report that lymphatic endothelial cells might have undergone persistent genetic alterations of TSC2 and TP53, which eventually lead to malignant transformation toward angiosarcoma. Thirdly, angiosarcoma cells might have been derived from AML cells as a malignant transformation. However, in this case the angiosarcoma cells expressed neither Melan-A nor HMB45, and the immunoprofile of angiosarcoma clearly differed from that of renal AML. Even so, we cannot exclude the possibility that the renal angiosarcoma is simply a de novo occurrence other than associated with the AML lesion. However, more studies were needed to investigate the correlation between angiosarcoma and PEComas.

The prognosis of renal angiosarcoma is deadly because of local recurrence and extensive metastasis. At present, there appears to be no standard therapy because of the rarity of this malignancy. Most patients were treated with nephrectomy combined with radiotherapy, chemotherapy or recombinant interleukin-2 therapy [2, 30]. The optimal treatment still remains controversial. However, surgery seems to be the most effective treatment. In this case, the patient only received partial nephrectomy combined with intraperitoneal cisplatin perfusion and symptomatic treatment. Nevertheless, she died four months after the surgery, confirming the fatal prognosis of renal angiosarcoma.

Conclusions

In conclusion, we described here, for the first time, a primary renal angiosarcoma possibly arising in an AML, and the AML might be the precursor of the primary angiosarcoma of the kidney. However, more studies are needed to detect the correlation between the two.

Abbreviations

AML: 

Angiomyolipoma

AS: 

Angiosarcoma

CT: 

Computed tomography

LAM: 

Lymphangioleiomyomatosis

PEComa: 

Perivascular epithelioid cell tumor

TSC: 

Tuberous sclerosis complex

Declarations

Acknowledgements

We thank Dr. Bulang Gao for revising the manuscript.

Funding

This project was supported by the National Natural Science Foundation of China (Nos 81502274).

Availability of data and materials

As a case report, all data generated or analyzed are included in this article.

Authors’ contributions

HW and HG drafted this manuscript. HG, LZ and QZ made the final diagnosis. HW and SX analyzed and interpreted the patient data. WQ and JH evaluated the histopathological images and prepared the figures. All authors read and approved the final manuscript.

Ethics approval and consent to participate

Not applicable.

Consent for publication

Written informed consent for publication of the clinical details and/or clinical images was obtained from the patient. A copy of the consent form is available for review by the editor of this journal.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Department of Pathology, Dalian Medical University First Hospital, 222 Zhongshan Road, Xigang District, Dalian, 116011, Liaoning, China

References

  1. Deyrup AT, Miettinen M, North PE, Khoury JD, Tighiouart M, Spunt SL, Parham D, Weiss SW, Shehata BM. Angiosarcomas arising in the viscera and soft tissue of children and young adults: a clinicopathologic study of 15 cases. Am J Surg Pathol. 2009;33:264–9.View ArticlePubMedGoogle Scholar
  2. Omiyale AO. Clinicopathological features of primary angiosarcoma of the kidney: a review of 62 cases. Transl Androl Urol. 2015;4:464–73.PubMedPubMed CentralGoogle Scholar
  3. Zenico T, Saccomanni M, Salomone U, Bercovich E. Primary renal angiosarcoma: case report and review of world literature. Tumori. 2011;97:e6–9.View ArticlePubMedGoogle Scholar
  4. Martignoni G, Pea M, Reghellin D, Zamboni G, Bonetti F. PEComas: the past, the present and the future. Virchows Arch. 2008;452:119–32.View ArticlePubMedGoogle Scholar
  5. Moch H, Humphrey PA, Ulbright TM, Reuter VE. WHO Classification of Tumours of the Urinary System and Male Genital Organs. LARC, Lyon. 2016; p. 62–64.Google Scholar
  6. Zapardiel I, Delafuente-Valero J, Bajo-Arenas JM. Renal angiomyolipoma during pregnancy: review of the literature. Gynecol Obstet Investig. 2011;72:217–9.View ArticleGoogle Scholar
  7. Young RJ, Brown NJ, Reed MW, Hughes D, Woll PJ. Angiosarcoma. Lancet Oncol. 2010;11:983–91.View ArticlePubMedGoogle Scholar
  8. Cohen SM, Storer RD, Criswell KA, Doerrer NG, Dellarco VL, Pegg DG, Wojcinski ZW, Malarkey DE, Jacobs AC, Klaunig JE, et al. Hemangiosarcoma in rodents: mode-of-action evaluation and human relevance. Toxicol Sci. 2009;111:4–18.View ArticlePubMedGoogle Scholar
  9. Yang J, Kantrow S, Sai J, Hawkins OE, Boothby M, Ayers GD, Young ED, Demicco EG, Lazar AJ, Lev D, Richmond A. INK4a/ARF [corrected] inactivation with activation of the NF-kappaB/IL-6 pathway is sufficient to drive the development and growth of angiosarcoma. Cancer Res. 2012;72:4682–95.View ArticlePubMedPubMed CentralGoogle Scholar
  10. Penel N, Marreaud S, Robin YM, Hohenberger P. Angiosarcoma: state of the art and perspectives. Crit Rev Oncol Hematol. 2011;80:257–63.View ArticlePubMedGoogle Scholar
  11. Brown JG, Folpe AL, Rao P, Lazar AJ, Paner GP, Gupta R, Parakh R, Cheville JC, Amin MB. Primary vascular tumors and tumor-like lesions of the kidney: a clinicopathologic analysis of 25 cases. Am J Surg Pathol. 2010;34:942–9.View ArticlePubMedGoogle Scholar
  12. Papadimitriou VD, Stamatiou KN, Takos DM, Adamopoulos VM, Heretis IE, Sofras FA. Angiosarcoma of kidney: a case report and review of literature. Urol J. 2009;6:223–5.PubMedGoogle Scholar
  13. Akkad T, Tsankov A, Pelzer A, Peschel R, Bartsch G, Steiner H. Early diagnosis and straight forward surgery of an asymptomatic primary angiosarcoma of the kidney led to long-term survival. Int J Urol. 2006;13:1112–4.View ArticlePubMedGoogle Scholar
  14. Popper H, Thomas LB, Telles NC, Falk H, Selikoff IJ. Development of hepatic angiosarcoma in man induced by vinyl chloride, thorotrast, and arsenic. Comparison with cases of unknown etiology. Am J Pathol. 1978;92:349–76.PubMedPubMed CentralGoogle Scholar
  15. Trassard M, Le Doussal V, Bui BN, Coindre JM. Angiosarcoma arising in a solitary schwannoma (neurilemoma) of the sciatic nerve. Am J Surg Pathol. 1996;20:1412–7.View ArticlePubMedGoogle Scholar
  16. Brown RW, Tornos C, Evans HL. Angiosarcoma arising from malignant schwannoma in a patient with neurofibromatosis. Cancer. 1992;70:1141–4.View ArticlePubMedGoogle Scholar
  17. Meis-Kindblom JM, Kindblom LG. Angiosarcoma of soft tissue: a study of 80 cases. Am J Surg Pathol. 1998;22:683–97.View ArticlePubMedGoogle Scholar
  18. Fletcher CD, Beham A, Bekir S, Clarke AM, Marley NJ. Epithelioid angiosarcoma of deep soft tissue: a distinctive tumor readily mistaken for an epithelial neoplasm. Am J Surg Pathol. 1991;15:915–24.View ArticlePubMedGoogle Scholar
  19. Ulbright TM, Clark SA, Einhorn LH. Angiosarcoma associated with germ cell tumors. Hum Pathol. 1985;16:268–72.View ArticlePubMedGoogle Scholar
  20. Tallini G, Price FV, Carcangiu ML. Epithelioid angiosarcoma arising in uterine leiomyomas. Am J Clin Pathol. 1993;100:514–8.View ArticlePubMedGoogle Scholar
  21. Hayashi T, Koike K, Kumasaka T, Saito T, Mitani K, Terao Y, Ogishima D, Yao T, Takeda S, Takahashi K, Seyama K. Uterine angiosarcoma associated with lymphangioleiomyomatosis in a patient with tuberous sclerosis complex: an autopsy case report with immunohistochemical and genetic analysis. Hum Pathol. 2012;43:1777–84.View ArticlePubMedGoogle Scholar
  22. Pillay K, Lazarus J, Wainwright HC. Association of angiomyolipoma and oncocytoma of the kidney: a case report and review of the literature. J Clin Pathol. 2003;56:544–7.View ArticlePubMedPubMed CentralGoogle Scholar
  23. van Slegtenhorst M, de Hoogt R, Hermans C, Nellist M, Janssen B, Verhoef S, Lindhout D, van den Ouweland A, Halley D, Young J, et al. Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science. 1997;277:805–8.View ArticlePubMedGoogle Scholar
  24. European Chromosome 16 Tuberous Sclerosis Consortium. Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell. 1993;75:1305–15.View ArticleGoogle Scholar
  25. Kwiatkowski DJ. Tuberous sclerosis: from tubers to mTOR. Ann Hum Genet. 2003;67:87–96.View ArticlePubMedGoogle Scholar
  26. Kenerson H, Folpe AL, Takayama TK, Yeung RS. Activation of the mTOR pathway in sporadic angiomyolipomas and other perivascular epithelioid cell neoplasms. Hum Pathol. 2007;38:1361–71.View ArticlePubMedPubMed CentralGoogle Scholar
  27. Tamboli P, Ro JY, Amin MB, Ligato S, Ayala AG. Benign tumors and tumor-like lesions of the adult kidney. Part II: benign mesenchymal and mixed neoplasms, and tumor-like lesions. Adv Anat Pathol. 2000;7:47–66.View ArticlePubMedGoogle Scholar
  28. Italiano A, Chen CL, Thomas R, Breen M, Bonnet F, Sevenet N, Longy M, Maki RG, Coindre JM, Antonescu CR. Alterations of the p53 and PIK3CA/AKT/mTOR pathways in angiosarcomas: a pattern distinct from other sarcomas with complex genomics. Cancer. 2012;118:5878–87.View ArticlePubMedPubMed CentralGoogle Scholar
  29. Lahat G, Dhuka AR, Hallevi H, Xiao L, Zou C, Smith KD, Phung TL, Pollock RE, Benjamin R, Hunt KK, et al. Angiosarcoma: clinical and molecular insights. Ann Surg. 2010;251:1098–106.View ArticlePubMedGoogle Scholar
  30. Iacovelli R, Orlando V, Palazzo A, Cortesi E. Clinical and pathological features of primary renal angiosarcoma. Can Urol Assoc J. 2014;8:E223–6.View ArticlePubMedPubMed CentralGoogle Scholar

Copyright

© The Author(s). 2018

Advertisement